Research Paper
microRNA-212 inhibits nasopharyngeal carcinoma progression through targeting TPD52 and inhibiting EMT and Wnt/β-catenin pathway
Figure 1. Downregulation of miR-212 in NPC tissues and cell lines. (A) Low miR-212 expression was observed in NPC tissues. N=33 in each group. (B) Relative MiR-212 expression levels in C666-1, 6-10B and NP69 cell lines. N=4 in each group. (C) Low miR-212 expression was associated with worse NPC prognosis. (D) Low miR-212 expression in NPC was found in public available study cohorts in TCGA database (N=102). *p < 0.05, ** p <0.01.